当前位置:首页 - 行情中心 - 艾迪药业(688488) - 财务分析 - 现金流量表

艾迪药业

(688488)

  

流通市值:90.89亿  总市值:90.89亿
流通股本:4.21亿   总股本:4.21亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金511,289,444.93337,709,529.25174,325,396.22504,266,356.01
  收到的税费返还---3,643,027.61
  收到其他与经营活动有关的现金111,673,725.5171,758,605.3975,317,634.7489,773,697.26
  经营活动现金流入小计622,963,170.44409,468,134.64249,643,030.96597,683,080.88
  购买商品、接受劳务支付的现金103,839,174.8466,713,327.0826,974,782.03220,069,821.59
  支付给职工以及为职工支付的现金112,839,403.3178,264,424.2944,032,775.47115,392,755.01
  支付的各项税费73,843,852.8337,611,921.7816,957,341.7626,513,413.45
  支付其他与经营活动有关的现金304,951,912.33202,430,065.28121,923,961.08273,204,880.62
  经营活动现金流出小计595,474,343.31385,019,738.43209,888,860.34635,180,870.67
  经营活动产生的现金流量净额27,488,827.1324,448,396.2139,754,170.62-37,497,789.79
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,221,649.87697,756.63411,961.734,192,094.18
  处置固定资产、无形资产和其他长期资产收回的现金净额119,850--120,963.14
  收到的其他与投资活动有关的现金314,400,000199,400,000106,000,000836,346,510.55
  投资活动现金流入小计315,741,499.87200,097,756.63106,411,961.73840,659,567.87
  购建固定资产、无形资产和其他长期资产支付的现金18,405,450.0416,599,571.6110,535,646.2144,561,428.63
  投资支付的现金1,750,0001,750,0001,750,000-
  取得子公司及其他营业单位支付的现金5,040,0005,040,000--
  支付其他与投资活动有关的现金285,000,000185,000,00030,000,000711,000,000
  投资活动现金流出小计310,195,450.04208,389,571.6142,285,646.21755,561,428.63
  投资活动产生的现金流量净额5,546,049.83-8,291,814.9864,126,315.5285,098,139.24
三、筹资活动产生的现金流量:
  取得借款收到的现金371,924,000312,024,000200,000,000410,868,000
  筹资活动现金流入小计371,924,000312,024,000200,000,000410,868,000
  偿还债务支付的现金373,706,000266,012,000204,962,000336,400,000
  分配股利、利润或偿付利息支付的现金16,549,784.0412,726,499.594,198,189.5515,852,126.44
  支付其他与筹资活动有关的现金1,896,009.491,833,676.091,357,256.613,752,967.48
  筹资活动现金流出小计392,151,793.53280,572,175.68210,517,446.16356,005,093.92
  筹资活动产生的现金流量净额-20,227,793.5331,451,824.32-10,517,446.1654,862,906.08
四、汇率变动对现金及现金等价物的影响-47,703.57-8,346.65444.4-6,588.77
五、现金及现金等价物净增加额12,759,379.8647,600,058.993,363,484.38102,456,666.76
  加:期初现金及现金等价物余额324,259,532.77324,259,532.77324,259,532.77221,802,866.01
  期末现金及现金等价物余额337,018,912.63371,859,591.67417,623,017.15324,259,532.77
补充资料:
  净利润-26,489,470.65--138,835,089.7
  资产减值准备-2,896,425.23-65,199,313.37
  固定资产和投资性房地产折旧-16,952,447.15-33,197,184.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-16,952,447.15-33,197,184.19
  无形资产摊销-9,461,335.39-14,696,691.6
  长期待摊费用摊销-2,501,848.84-3,530,890.53
  处置固定资产、无形资产和其他长期资产的损失--99,170.37--
  固定资产报废损失-137,770.56-431,561.44
  公允价值变动损失--14,218,294.32--10,763,010.03
  财务费用-8,096,590.56-15,360,254.21
  投资损失-568,771.59--6,962,716.68
  递延所得税-1,201,361.07--29,081,563.23
  其中:递延所得税资产减少--167,758.08--24,762,435.4
    递延所得税负债增加-1,369,119.15--4,319,127.83
  存货的减少--14,315,826.18--44,277,491.41
  经营性应收项目的减少--11,736,449.13-76,977,305.96
  经营性应付项目的增加--4,162,332.96--14,342,956.61
  其他--482,055.71--5,314,820.51
  现金的期末余额-371,859,591.67-324,259,532.77
  减:现金的期初余额-324,259,532.77-221,802,866.01
  现金及现金等价物的净增加额-47,600,058.9-102,456,666.76
公告日期2025-10-312025-08-292025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑